In a transgenic mouse model, MAP17 hepatic overexpression resulted in PDZK1 (NHeRF3) liver deficiency, suggesting that MAP17 is an endogenous regulator of PDZK1 turnover (Silver et al., 2003). This evidence concerns the gene PDZK1 and hyperinsulinemic hypoglycemia, familial, 4.